Viewing Study NCT00104468

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:43 PM
Ignite Modification Date: 2026-02-02 @ 2:31 AM
Study NCT ID: NCT00104468
Status: TERMINATED
Last Update Posted: 2008-01-17
First Post: 2005-02-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML)
Sponsor: SGX Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myelogenous Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Single-arm, open-label, multi-center, dose escalation, continuous infusion, multi-dose, acute myeloid … View
None Acute myelogenous leukemia (AML) that has been refractory to prior … View